tetano
Editor, Senior Moderator
Cureus
. 2022 Jan 25;14(1):e21605.
doi: 10.7759/cureus.21605. eCollection 2022 Jan.
Home Management of COVID-19 Patients: A Successful Model in Non-severe COVID-19 Patients in the Developing World
Syed Alishan[SUP] 1 [/SUP], Farheen Ali[SUP] 2 [/SUP], Zafar Iqbal[SUP] 3 [/SUP], Ali Ammar[SUP] 1 [/SUP], Atif S Muhammad[SUP] 3 [/SUP], Faiza Farooq[SUP] 1 [/SUP], Ayaz Mir[SUP] 4 [/SUP], Nawal Salahuddin[SUP] 5 6 [/SUP], Tahir Saghir[SUP] 3 [/SUP], Musa Karim[SUP] 7 [/SUP]
Affiliations
Abstract
Background Around 80-85% of coronavirus disease 2019 (COVID-19) cases were reported to have mild disease and home treatment of such patients was proved to be effective without significant morbidity or mortality. Therefore, the aim of this study was to assess the outcome of home management of non-severe COVID-19 infection in healthcare providers in the developing world. Methods This observational cohort study was conducted at the National Institute of Cardiovascular Diseases from June 2020 till January 2021. It included health care workers who tested positive for COVID-19 with non-severe infection and received home treatment. The COVID-19 management team monitored their symptoms and oxygen saturation over the phone. Need-based lab tests, X-rays, home proning, steroids, and oxygen were administered along with the standard intuitional management strategies. Study outcomes included duration of recovery, need for hospitalization, and expiry. Results A total of 128 patients were included, out of which 98 (76.6%) were male, and the mean age was 32.9 ± 5.9 years. Fever was the most common symptom, seen in 89.8% of patients. Most of the patients (85.9%) had no pre-existing comorbidities. Five patients received home oxygen therapy, seven received steroid therapy, and one received home pruning. The average time of recovery was 13.8 ± 8.1 days with no mortality; however, 14 (10.9%) patients were hospitalized due to worsening of symptoms. Conclusion Home treatment for COVID-19 patients with mild to moderate disease after appropriate risk assessment can be a safe and effective option to preserve hospital capacities for more needy and severely ill patients.
Keywords: covid-19; home management; pandemic; risk assessment; treatment.
. 2022 Jan 25;14(1):e21605.
doi: 10.7759/cureus.21605. eCollection 2022 Jan.
Home Management of COVID-19 Patients: A Successful Model in Non-severe COVID-19 Patients in the Developing World
Syed Alishan[SUP] 1 [/SUP], Farheen Ali[SUP] 2 [/SUP], Zafar Iqbal[SUP] 3 [/SUP], Ali Ammar[SUP] 1 [/SUP], Atif S Muhammad[SUP] 3 [/SUP], Faiza Farooq[SUP] 1 [/SUP], Ayaz Mir[SUP] 4 [/SUP], Nawal Salahuddin[SUP] 5 6 [/SUP], Tahir Saghir[SUP] 3 [/SUP], Musa Karim[SUP] 7 [/SUP]
Affiliations
- PMID: 35228963
- PMCID: PMC8870052
- DOI: 10.7759/cureus.21605
Abstract
Background Around 80-85% of coronavirus disease 2019 (COVID-19) cases were reported to have mild disease and home treatment of such patients was proved to be effective without significant morbidity or mortality. Therefore, the aim of this study was to assess the outcome of home management of non-severe COVID-19 infection in healthcare providers in the developing world. Methods This observational cohort study was conducted at the National Institute of Cardiovascular Diseases from June 2020 till January 2021. It included health care workers who tested positive for COVID-19 with non-severe infection and received home treatment. The COVID-19 management team monitored their symptoms and oxygen saturation over the phone. Need-based lab tests, X-rays, home proning, steroids, and oxygen were administered along with the standard intuitional management strategies. Study outcomes included duration of recovery, need for hospitalization, and expiry. Results A total of 128 patients were included, out of which 98 (76.6%) were male, and the mean age was 32.9 ± 5.9 years. Fever was the most common symptom, seen in 89.8% of patients. Most of the patients (85.9%) had no pre-existing comorbidities. Five patients received home oxygen therapy, seven received steroid therapy, and one received home pruning. The average time of recovery was 13.8 ± 8.1 days with no mortality; however, 14 (10.9%) patients were hospitalized due to worsening of symptoms. Conclusion Home treatment for COVID-19 patients with mild to moderate disease after appropriate risk assessment can be a safe and effective option to preserve hospital capacities for more needy and severely ill patients.
Keywords: covid-19; home management; pandemic; risk assessment; treatment.